A study on drug attitude among patients with schizophrenia and bipolar affective disorders

Background: Medication non compliance is a common and difficult problem in the treatment of chronic disorders in general and psychiatric disorders in particular. This results in relapses, exacerbations, recurrences and frequent hospitalizations. It affects the quality of life of patients and increas...

Full description

Bibliographic Details
Main Authors: Sivanandh Budarapu, Lokeswara P Reddy, Sudhakar P Thatikonda
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2016-01-01
Series:Archives of Mental Health
Subjects:
Online Access:http://www.amhonline.org/article.asp?issn=2589-9171;year=2016;volume=17;issue=1;spage=24;epage=31;aulast=Budarapu;type=0
_version_ 1819319468746080256
author Sivanandh Budarapu
Lokeswara P Reddy
Sudhakar P Thatikonda
author_facet Sivanandh Budarapu
Lokeswara P Reddy
Sudhakar P Thatikonda
author_sort Sivanandh Budarapu
collection DOAJ
description Background: Medication non compliance is a common and difficult problem in the treatment of chronic disorders in general and psychiatric disorders in particular. This results in relapses, exacerbations, recurrences and frequent hospitalizations. It affects the quality of life of patients and increases the caregiver burden of the family members. Among various factors which affect non compliance patients attitude to drugs is one potentially modifiable aspect which is attracting attention in patient care. Aims: To study the attitude of patients with schizophrenia and bipolar affective disorder towards drugs and modify any negative attitudes about the drugs. Methodology: Apart from the sociodemographic variables, Drug attitude inventory (DAI) was used to assess the attitude of patients and WHO- Quality of Life (WHO-QOL) was used to assess quality of life of study group patients both at the baseline and during the follow-up. Results: In the bipolar group, 80% of the participants achieved good compliance status from the baseline of 17.8% and in the schizophrenia group 82.2% achieved good compliance compared to 20% at baseline. Their quality of life also improved in all domains. Conclusion: Carefully planned medication counseling to patients and family members and appropriate corrections in the medication appears to show great change in compliance. A little effort put in by treating team can change the quality of life of many patients with psychiatric disorders.
first_indexed 2024-12-24T11:04:10Z
format Article
id doaj.art-a0a2dfab112646a48e5c3a2ed215337e
institution Directory Open Access Journal
issn 2589-9171
2589-918X
language English
last_indexed 2024-12-24T11:04:10Z
publishDate 2016-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Archives of Mental Health
spelling doaj.art-a0a2dfab112646a48e5c3a2ed215337e2022-12-21T16:58:40ZengWolters Kluwer Medknow PublicationsArchives of Mental Health2589-91712589-918X2016-01-011712431A study on drug attitude among patients with schizophrenia and bipolar affective disordersSivanandh BudarapuLokeswara P ReddySudhakar P ThatikondaBackground: Medication non compliance is a common and difficult problem in the treatment of chronic disorders in general and psychiatric disorders in particular. This results in relapses, exacerbations, recurrences and frequent hospitalizations. It affects the quality of life of patients and increases the caregiver burden of the family members. Among various factors which affect non compliance patients attitude to drugs is one potentially modifiable aspect which is attracting attention in patient care. Aims: To study the attitude of patients with schizophrenia and bipolar affective disorder towards drugs and modify any negative attitudes about the drugs. Methodology: Apart from the sociodemographic variables, Drug attitude inventory (DAI) was used to assess the attitude of patients and WHO- Quality of Life (WHO-QOL) was used to assess quality of life of study group patients both at the baseline and during the follow-up. Results: In the bipolar group, 80% of the participants achieved good compliance status from the baseline of 17.8% and in the schizophrenia group 82.2% achieved good compliance compared to 20% at baseline. Their quality of life also improved in all domains. Conclusion: Carefully planned medication counseling to patients and family members and appropriate corrections in the medication appears to show great change in compliance. A little effort put in by treating team can change the quality of life of many patients with psychiatric disorders.http://www.amhonline.org/article.asp?issn=2589-9171;year=2016;volume=17;issue=1;spage=24;epage=31;aulast=Budarapu;type=0attitude towards drugsschizophreniabipolar disorder
spellingShingle Sivanandh Budarapu
Lokeswara P Reddy
Sudhakar P Thatikonda
A study on drug attitude among patients with schizophrenia and bipolar affective disorders
Archives of Mental Health
attitude towards drugs
schizophrenia
bipolar disorder
title A study on drug attitude among patients with schizophrenia and bipolar affective disorders
title_full A study on drug attitude among patients with schizophrenia and bipolar affective disorders
title_fullStr A study on drug attitude among patients with schizophrenia and bipolar affective disorders
title_full_unstemmed A study on drug attitude among patients with schizophrenia and bipolar affective disorders
title_short A study on drug attitude among patients with schizophrenia and bipolar affective disorders
title_sort study on drug attitude among patients with schizophrenia and bipolar affective disorders
topic attitude towards drugs
schizophrenia
bipolar disorder
url http://www.amhonline.org/article.asp?issn=2589-9171;year=2016;volume=17;issue=1;spage=24;epage=31;aulast=Budarapu;type=0
work_keys_str_mv AT sivanandhbudarapu astudyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders
AT lokeswarapreddy astudyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders
AT sudhakarpthatikonda astudyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders
AT sivanandhbudarapu studyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders
AT lokeswarapreddy studyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders
AT sudhakarpthatikonda studyondrugattitudeamongpatientswithschizophreniaandbipolaraffectivedisorders